美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,289.82

+40.123.21%

漲家數：5

跌家數：2

平家數：- -

市盈率：- -

高：1,301.32

開：1,249.67

低：1,249.67

收：1,249.70

資料載入中...

Viking Therapeutics, Inc.盤中異動早盤大幅下挫5.03%報24.37美元

諾和諾德盤中異動早盤快速下挫2.92%

美國法官駁回禁令！諾和諾德(NVO.US)減肥神藥仿製版生產遭“封殺”

智通财经网

輝瑞英立達獲批國內首個且唯一晚期腎癌一線靶免聯合治療

輝瑞：阿昔替尼獲批中國首個且唯一晚期腎癌一線靶免聯合治療

幣安將於 5 月 7 日下架多個槓桿交易對

Binance將於5月7日移除部分槓桿交易對

幣安將於5月7日下架多個槓桿交易對

輝瑞4月24日成交額為7.94億美元

諾和諾德4月24日成交額為4.92億美元

禮來4月24日成交額為25.08億美元

健康巡講：接觸細菌毒素可能是結腸癌發病年齡提前的原因

【歐股“十一羅漢”｜羅氏收漲超1.9%，阿斯麥漲超1.8%】週四，阿斯麥控股荷蘭阿姆斯特丹股價收漲1.86%，報591.70歐元。諾和諾德哥本哈根股價收漲0.29%，報410.10。羅氏製藥、歐萊雅、LVMH集團、諾華、葛蘭素史克漲1.94%-1.09%，阿斯利康、賽諾菲、雀巢至多漲0.79%，德國思愛普Sap則跌0.23%。

百時美施貴寶因抗癌藥物銷售而實現高於預期的季度收入

禮來盤中異動早盤大幅拉昇3.01%

癌症藥物銷售強勁，百時美施貴寶季度收入好於預期

洞察力-美國食品和藥物管理局推遲批准諾華公司的 COVID 疫苗，患者奮起反擊

BUZZ-Galderma 第一季度注射美容業績強勁，股價攀升

諾和諾德憑藉Wegovy大幅上調銷售指引的輝煌勢頭或近尾聲

羅氏：美國的投資計劃不會犧牲世界其他地區的利益

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1289.8245,"timestamp":1746215999999,"preClose":1249.7039,"halted":0,"volume":75845285,"delay":0,"changeRate":0.032104,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":40.120605,"latestTime":"05-02 16:00:00 EDT","open":1249.6709,"high":1301.315,"low":1249.6709,"amount":8375367350.76205,"amplitude":0.041325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":10.663316,"peRate":37.494675,"turnoverRate":0.00718,"increases":5,"decrements":2,"flats":0,"marketCap":1381836112544,"floatMarketCap":1292379014240},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1301.315,"amplitude":0.041325,"preClose":1249.7039,"low":1249.6709,"pbRate":"10.663316","latestPrice":1289.8245,"volume":75845285,"delay":0,"open":1249.6709,"prevYearClose":1305.0607,"prevWeekClose":1313.4298,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1313.4298,"twentyDayClose":1265.6132,"sixtyDayClose":1394.0055,"secType":"PLATE","market":"US","turnoverRate":0.00718,"peRate":37.494675,"marketCap":1381836112544,"floatMarketCap":1292379014240,"timestamp":1746215999999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530132873","title":"Viking Therapeutics, Inc.盤中異動 早盤大幅下挫5.03%報24.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530132873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530132873?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 21:55","pubTimestamp":1745589310,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时55分，Viking Therapeutics, Inc.股票出现波动，股价快速下挫5.03%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。该信息摘要如下：大摩：维持Viking Therapeutics评级，由增持调整至增持评级, 目标价由105.00美元调整至102.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215510a466e83e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215510a466e83e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VKTX","BK4007","BK4139","BK4599","BK4585","BK4588"],"gpt_icon":0},{"id":"2530131602","title":"諾和諾德盤中異動 早盤快速下挫2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530131602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530131602?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 21:31","pubTimestamp":1745587882,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分，诺和诺德股票出现波动，股价大幅跳水2.92%。诺和诺德股票所在的制药行业中，整体跌幅为0.18%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。该信息摘要如下：自2021年推出广受欢迎的减肥药Wegovy以来，诺和诺德每年多次上调年度销售指引。诺和诺德2月曾表示，其已增加Wegovy在美国的供应以满足激增需求，并称指引已反映这一调整。诺和诺德称，该禁令可能将需求转向其正版产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213122a6c81ce2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213122a6c81ce2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4532","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4588","IE00BKVL7J92.USD","LU1093756168.USD","BK4007","BK4585","BK4599","NVO"],"gpt_icon":1},{"id":"2530364541","title":"美國法官駁回禁令！諾和諾德(NVO.US)減肥神藥仿製版生產遭“封殺”","url":"https://stock-news.laohu8.com/highlight/detail?id=2530364541","media":"智通财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530364541?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 21:04","pubTimestamp":1745586240,"startTime":"0","endTime":"0","summary":"周四，美国一名地区法官驳回了一家复合药行业组织提出的一项禁令申请，该申请旨在继续生产诺和诺德减肥药Ozempic和Wegovy低价仿制版本，即便此前美国食品药品监督管理局已声明，这类GLP-1受体激动剂药物不再处于短缺状态。据媒体援引法庭记录报道，美国得克萨斯州地区法官Mark Pittman驳回了原告方关于初步禁令的动议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2025-04-25/doc-ineukxcu4877747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","NVO","LU1093756325.SGD","BK4532","BK4588","LU1093756168.USD","BK4585"],"gpt_icon":1},{"id":"2530905116","title":"輝瑞英立達 獲批國內首個且唯一晚期腎癌一線靶免聯合治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905116","media":"21经济网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530905116?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 16:57","pubTimestamp":1745571434,"startTime":"0","endTime":"0","summary":"南方财经4月25日电，辉瑞公司今日宣布，其口服靶向药英立达?（Inlyta?，通用名：阿昔替尼片）于2025年4月22日获得国家药品监督管理局（NMPA）批准，联合特瑞普利单抗用于中高危的不可切除或转移性肾细胞癌（RCC）患者的一线治疗，这也是中国肾癌治疗领域首个且唯一获批的一线靶免联合治疗方案。（21世纪经济报道）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999011175.SGD","LU0306807586.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1894683348.USD","BK4585","BK4592","BK4007","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","IE00BLSP4452.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1883839398.USD","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","LU0306806265.USD","SG9999002232.USD","LU1894683264.USD","BK4599","IE0002270589.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0225771236.USD","LU1023059063.AUD","SG9999003800.SGD","BK4533","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","PFE","LU0456855351.SGD","LU0321505439.SGD"],"gpt_icon":0},{"id":"2530970288","title":"輝瑞：阿昔替尼獲批中國首個且唯一晚期腎癌一線靶免聯合治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2530970288","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530970288?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 16:55","pubTimestamp":1745571304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0456855351.SGD","LU0306807586.USD","LU1066051498.USD","LU0985481810.HKD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4585","BK4599","LU1894683264.USD","LU1057294990.SGD","SG9999001176.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1894683348.USD","BK4581","BK4533","BK4534","BK4588","LU0306806265.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999001176.SGD","BK4007","LU0225284248.USD","RCC","LU0868494617.USD","IE00B19Z3581.USD","SG9999013999.USD","IE000M9KFDE8.USD","BK4550","IE00BLSP4239.USD","IE0002270589.USD","LU0225771236.USD","LU1066053197.SGD","LU0321505439.SGD","LU0234572021.USD","SG9999002224.SGD","LU0170899867.USD","LU0289739699.SGD","BK4568","SG9999003800.SGD","LU1023059063.AUD","LU0122379950.USD","PFE","BK4592","SG9999002232.USD","LU0321505868.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2530630947","title":"幣安將於 5 月 7 日下架多個槓桿交易對","url":"https://stock-news.laohu8.com/highlight/detail?id=2530630947","media":"foresightnews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530630947?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 12:05","pubTimestamp":1745553900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://foresightnews.pro/foresightnews/news/detail/71410","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"foresightnews_live","symbols":["IE00B7SZLL34.SGD","SG9999014914.USD","TRU","ALT","BTCmain","SG9999014880.SGD","LU1878469433.USD","BK4588","BK4505","BK4550","LU2264538146.SGD","SGXZ23171101.USD","SG9999015978.USD","SG9999017495.SGD","IE00B19Z3B42.SGD","BK4585","BK4535","SG9999004303.SGD","LU0642271901.SGD","LU0719512351.SGD","IE00BFMHRM44.USD","LU1316542783.SGD","SG9999015986.USD","SG9999014898.SGD","BTC","LU2360107325.USD","SG9999018857.SGD","SG9999015945.SGD","UBER","BK4599","LU1989764664.SGD","BK4123","LU1988902786.USD","LU2087625088.SGD","SG9999014906.USD","LU1064131342.USD","SG9999018865.SGD","SGXZ31699556.SGD","SG9999015952.SGD","LU1169589451.USD","LU0006306889.USD","LU0106261372.USD","XBTmain","BK4551","BIO","LU0127658192.USD","BK4503","LU1169590202.USD","IE00BZ199S13.USD","BTC.USD.HKCC"],"gpt_icon":0},{"id":"2530947004","title":"Binance將於5月7日移除部分槓桿交易對","url":"https://stock-news.laohu8.com/highlight/detail?id=2530947004","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530947004?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 12:02","pubTimestamp":1745553720,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/291189","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BTC","TRU","BK4585","BK4139","LU1878469433.USD","USDC","ALT","XBTmain","LU1989764748.USD","BK4599","LU1169589451.USD","BK4123","BTC.USD.HKCC","SG9999004303.SGD","LU1169590202.USD","BTCmain","BK4121","TST","SGXZ23171101.USD","BIO","BK4588","LU1989764664.SGD"],"gpt_icon":0},{"id":"2530994736","title":"幣安將於5月7日下架多個槓桿交易對","url":"https://stock-news.laohu8.com/highlight/detail?id=2530994736","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530994736?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 12:01","pubTimestamp":1745553677,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 据官方公告，币安将于 2025 年 5 月 7 日 06：00（UTC）下架多个杠杆交易对，包括 ALT/FDUSD、BIO/FDUSD、GPS/FDUSD 等全仓杠杆交易对，以及 ALT/FDUSD、GPS/FDUSD、TRU/BTC 等逐仓杠杆交易对。5 月 2 日 06：00（UTC）起，币安将暂停上述逐仓杠杆交易对的借贷功能。建议用户在 5 月 7 日 06：00（UTC）前平仓或转移资产至现货账户。 （本条快讯由AI辅助生成）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/428484?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK4588","LU1878469433.USD","LU1989764664.SGD","BIO","BK4123","BTC","XBTmain","LU1169590202.USD","SGXZ23171101.USD","BTC.USD.HKCC","BK4139","BK4585","BK4121","LU1989764748.USD","ALT","SG9999004303.SGD","TRU","BK4599","LU1169589451.USD","BTCmain"],"gpt_icon":0},{"id":"2530911943","title":"輝瑞4月24日成交額為7.94億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530911943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530911943?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 10:18","pubTimestamp":1745547492,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，辉瑞成交额为7.94亿美元，成交额较昨日减少30.67%，当日成交量为3500.96万股。辉瑞于2025年4月24日涨1.74%，报22.78美元，该股过去5个交易日涨3.36%，年初至今跌12.71%，过去60日跌14.84%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|#|2025-04-17|12.06亿|44.24%|5407.37万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101820a4662ad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101820a4662ad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999003800.SGD","SG9999001176.SGD","LU0225771236.USD","LU0058720904.USD","LU1023059063.AUD","BK4533","LU0985481810.HKD","PFE","SG9999002232.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4007","BK4550","BK4588","LU0321505868.SGD","LU0306807586.USD","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","BK4585","BK4592","BK4568","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","SG9999013999.USD","LU0868494617.USD","LU1883839398.USD","LU1894683264.USD","BK4534","IE000M9KFDE8.USD","BK4581","LU0456855351.SGD","BK4599","SG9999011175.SGD","LU0170899867.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU0306806265.USD","LU1057294990.SGD","IE0002270589.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2530290943","title":"諾和諾德4月24日成交額為4.92億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530290943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530290943?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 10:11","pubTimestamp":1745547112,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，诺和诺德成交额为4.92亿美元，成交额较昨日减少12.38%，当日成交量为789.11万股。诺和诺德于2025年4月24日涨2.17%，报62.63美元，该股过去5个交易日跌0.4%，年初至今跌26.21%，过去60日跌25.48%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101153a4662937&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101153a4662937&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4599","BK4585","BK4532","LU1093756168.USD","BK4007","NVO","LU1093756325.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588"],"gpt_icon":1},{"id":"2530251943","title":"禮來4月24日成交額為25.08億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530251943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530251943?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 09:51","pubTimestamp":1745545899,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，礼来成交额为25.08亿美元，成交额较昨日增加11.26%，当日成交量为293.95万股。礼来于2025年4月24日涨3.65%，报859.73美元，该股过去5个交易日涨16.99%，年初至今涨11.55%，过去60日涨6.98%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|25.08亿|11.26%|293.95万|#|2025-04-23|22.54亿|-11.32%|271.46万|#|2025-04-22|25.41亿|-7.10%|308.65万|#|2025-04-21|27.35亿|-70.11%|332.66万|#|2025-04-17|91.53亿|275.58%|1085.34万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425095140a6c760de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425095140a6c760de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1988902786.USD","SG9999014898.SGD","LU2237443549.SGD","IE00B4R5TH58.HKD","SGXZ51526630.SGD","LU0882574055.USD","LLY","LU0006306889.USD","BK4007","LU1868837136.USD","LU0471298694.HKD","LU0106261372.USD","LU0820561909.HKD","LU0385154629.USD","LU0238689110.USD","IE00BK4W5L77.USD","LU1548497426.USD","LU1868836914.USD","LU2471134952.CNY","LU2237443465.HKD","LU1232071149.USD","LU2471134879.HKD","LU0198837287.USD","LU1069344957.HKD","LU1720051017.SGD","SG9999001176.USD","LU1035775433.USD","LU0471298777.SGD","LU0417517546.SGD","LU2361044865.SGD","BK4599","LU1720051108.HKD","LU2265009873.SGD","SG9999013999.USD","LU2357305700.SGD","LU0882574139.USD","IE0004445239.USD","SG9999014880.SGD","LU0320765059.SGD","LU1291159041.SGD","LU2491050154.USD","LU2106854487.HKD","LU1712237335.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","LU0823416689.USD","LU0456855351.SGD","LU1366192091.USD","LU1974910355.USD","LU1267930730.SGD"],"gpt_icon":1},{"id":"2530096489","title":"健康巡講：接觸細菌毒素可能是結腸癌發病年齡提前的原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2530096489","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530096489?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 03:08","pubTimestamp":1745521705,"startTime":"0","endTime":"0","summary":"今天，我们将介绍一项研究，该研究可能揭示了年轻人结肠癌发病率上升这一令人担忧的趋势背后的原因。儿童期肠道细菌可解释早发结肠癌 一项新的研究表明，儿童时期接触结肠中的一种细菌毒素可能会引发年轻患者结肠直肠癌病例的增加。两组的不良事件发生率相似。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R2243:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2530791963","title":"【歐股“十一羅漢”｜羅氏收漲超1.9%，阿斯麥漲超1.8%】 週四，阿斯麥控股荷蘭阿姆斯特丹股價收漲1.86%，報591.70歐元。諾和諾德哥本哈根股價收漲0.29%，報410.10。羅氏製藥、歐萊雅、LVMH集團、諾華、葛蘭素史克漲1.94%-1.09%，阿斯利康、賽諾菲、雀巢至多漲0.79%，德國思愛普Sap則跌0.23%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530791963","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530791963?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 01:36","pubTimestamp":1745516197,"startTime":"0","endTime":"0","summary":"周四，阿斯麦控股荷兰阿姆斯特丹股价收涨1.86%，报591.70欧元。诺和诺德哥本哈根股价收涨0.29%，报410.10。罗氏制药、欧莱雅、LVMH集团、诺华、葛兰素史克涨1.94%-1.09%，阿斯利康、赛诺菲、雀巢至多涨0.79%，德国思爱普Sap则跌0.23%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/25013649858510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4532","BK4007","GSK.UK","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2063271972.USD","LU0345774631.USD","BK4599","LU2417539215.USD","03165","BK4147","LRLCY","LU0211331839.USD","LU0320765489.SGD","01477","LU1093756168.USD","LU0208291251.USD","LU0154236417.USD","GSK","BK4183","IE0002141913.USD","BK4585","AZN","LU0070302665.USD","IE00B2B36J28.USD","NSRGY","BK4588","BK1574","IE0009355771.USD","BK1191","ASML","IE00BJT1NW94.SGD","LU1829250122.USD","LU2462157665.USD","LU0823434740.USD","BK4212","BK4578","IE00BJJMRZ35.SGD","LU1734074674.USD","IE00B4R5TH58.HKD","BK4568","IE0004445239.USD","NVS","LU2236285917.USD","BK4543","LU0097036916.USD","LU0889565916.HKD","LU0345774391.USD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2529953971","title":"百時美施貴寶因抗癌藥物銷售而實現高於預期的季度收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529953971","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529953971?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 23:16","pubTimestamp":1745507812,"startTime":"0","endTime":"0","summary":"更新版 1-百时美施贵宝因抗癌药物销售而实现高于预期的季度收入第 8-10 段增加了首席执行官在电话会议上对交易的评论，第 2 段增加了股票走势Michael Erman. 路透4月24日 - 百时美施贵宝BMY.N周四公布的第一季度营收高于预期，并上调了全年业绩预期，原因是其刺激病人免疫系统抗癌的药物组合实现了增长。这家美国制药商还受益于一些老药或非专利药的销售下降，如与辉瑞PFE.N共享的血液稀释剂Eliquis和血癌药物Revlimid的销售下降幅度低于预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R21UL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU1868836757.USD","IE00BFTCPJ56.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","IE00BLSP4452.SGD","BK4559","BK4534","SG9999013999.USD","LU1670710661.SGD","LU0122379950.USD","BMY","BK4581","BK4585","LU2125154935.USD","IE00BLSP4239.USD","LU1894683264.USD","LU1032466523.USD","LU0234572021.USD","SG9999002232.USD","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0061475181.USD","LU1718418525.SGD","BK4599","LU1093756325.SGD","IE00BJT1NW94.SGD","BK4588","LU1670711123.USD","BK4007","LU1074936037.SGD","IE00BBT3K403.USD","BK4568","LU1670710588.SGD","BK4592","LU0321505439.SGD","LU1093756168.USD","LU1571399168.USD","LU0306806265.USD","SG9999002224.SGD","LU0868494617.USD","LU1883839398.USD","BK4532","LU0170899867.USD","LU1989771016.USD","IE0002141913.USD","LU1430594728.SGD","BK4533"],"gpt_icon":1},{"id":"2530968296","title":"禮來盤中異動 早盤大幅拉昇3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530968296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530968296?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 23:15","pubTimestamp":1745507730,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日23时15分，礼来股票出现波动，股价快速上涨3.01%。截至发稿，该股报854.39美元/股，成交量91.882万股，换手率0.10%，振幅2.95%。机构评级方面，在所有29家参与评级的机构中，90%的券商给予买入建议，10%的券商给予持有建议，无券商给予卖出建议。礼来股票所在的制药行业中，整体涨幅为2.12%。消息层面，截至23时15分，《迎战礼来，诺和诺德抢先递交口服 GLP-1减重上市申请》资讯为影响礼来的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042423153094e134e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042423153094e134e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109391861.USD","LU1057294990.SGD","LU0882574055.USD","LLY","LU2461242641.AUD","LU0106261372.USD","LU0385154629.USD","LU2361044865.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","SGXZ99366536.SGD","LU2265009873.SGD","SG9999015986.USD","LU1868836591.USD","BK4588","BK4599","LU0079474960.USD","LU0203201768.USD","LU1366192091.USD","LU1267930730.SGD","IE00BJJMRZ35.SGD","LU2471134796.USD","SGXZ57979304.SGD","LU1868837136.USD","LU2602419157.SGD","LU0114720955.EUR","LU0256863811.USD","IE0002141913.USD","LU2211815571.USD","LU1551013342.USD","BK4533","LU0289739699.SGD","LU0096364046.USD","LU2023250504.SGD","LU2468319806.SGD","SG9999018857.SGD","LU2552382215.SGD","LU0417517546.SGD","LU0823416689.USD","GB00BDT5M118.USD","IE00B1BXHZ80.USD","BK4516","SGXZ81514606.USD","LU0708995401.HKD","LU0820561909.HKD","LU1917777945.USD","LU2750360641.GBP","LU1069344957.HKD","LU2552382058.USD","IE00BJLML261.HKD"],"gpt_icon":1},{"id":"2529602975","title":"癌症藥物銷售強勁，百時美施貴寶季度收入好於預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2529602975","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529602975?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 18:59","pubTimestamp":1745492347,"startTime":"0","endTime":"0","summary":"路透4月24日 - 百时美施贵宝BMY.N周四公布的第一季度营收好于预期，并上调了全年业绩预期，原因是其刺激患者自身免疫系统抗癌的药物组合实现了增长。埃尔金斯说，现在了解针对制药业的潜在关税的影响还为时过早，百时美施贵宝的预测不包括与此相关的任何假设。百时美施贵宝本季度营收的下降幅度低于华尔街分析师的预测，为 112 亿美元，低于去年同期的 119 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R210D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","LU1074936037.SGD","IE000M9KFDE8.USD","LU1718418525.SGD","LU0985481810.HKD","IE0002141913.USD","LU1585245621.USD","LU0321505439.SGD","BK4559","IE00BSNM7G36.USD","LU1066051498.USD","LU0321505868.SGD","BK4599","LU1894683264.USD","BK4568","LU1066053197.SGD","LU0170899867.USD","LU1093756168.USD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","BK4550","LU2133065610.SGD","BK4534","LU0061475181.USD","LU1883839398.USD","LU1571399168.USD","BK4533","LU2125154778.USD","IE00BLSP4239.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BK4585","LU1430594728.SGD","LU0306807586.USD","BK4532","SG9999001176.USD","LU2125154935.USD","LU2360032135.SGD","LU2242652126.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU1261432733.SGD","BK4588","LU0114720955.EUR","BMY"],"gpt_icon":1},{"id":"2529960877","title":"洞察力-美國食品和藥物管理局推遲批准諾華公司的 COVID 疫苗，患者奮起反擊","url":"https://stock-news.laohu8.com/highlight/detail?id=2529960877","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529960877?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 18:00","pubTimestamp":1745488804,"startTime":"0","endTime":"0","summary":"洞察力-美国食品和药物管理局推迟批准诺华公司的 COVID 疫苗，患者奋起反击长效 COVID 患者呼吁批准 Novavax美国食品和药物管理局推迟批准 Novavax，要求提供更多临床数据肯尼迪批评 Novavax，称单抗原疫苗无效Julie Steenhuysen. 本周三，该公司得到消息称，美国食品及药物管理局将考虑批准该疫苗 ，条件是 Novavax 同意在批准后提供更多有关该疫苗疗效的临床数据。如果没有 FDA 的批准，患者和疫苗专家表示，包括许多长期感染 COVID 的患者在内的一群人将失去保护自己的手段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R20US:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","SG9999001176.SGD","LU1066053197.SGD","BK4534","LU1066051498.USD","BK4501","BNTX","BK4547","LU0122379950.USD","SG9999001176.USD","BK4581","LU1894683348.USD","BK4139","LU1894683264.USD","LU0321505868.SGD","BK4592","IE00BBT3K403.USD","BK4550","SG9999002224.SGD","IE00B19Z3B42.SGD","NVAX","BK4599","LU0306806265.USD","BK4548","SG9999002232.USD","MRNA","BK4585","SG9999013999.USD","LU0225284248.USD","LU0289739699.SGD","LU1057294990.SGD","BK4532","BK4551","SG9999011175.SGD","BK4588","LU1023059063.AUD","LU0306807586.USD","LU0456855351.SGD","BK4533","LU0170899867.USD","LU0321505439.SGD","LU0058720904.USD","LU0868494617.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1883839398.USD","BK4535","SGXZ57979304.SGD","BK4568"],"gpt_icon":1},{"id":"2529625339","title":"BUZZ-Galderma 第一季度注射美容業績強勁，股價攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2529625339","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529625339?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 15:18","pubTimestamp":1745479131,"startTime":"0","endTime":"0","summary":"4月24日 -  ** Galderma GALD.S股价上涨 5.7%，该公司公布的第一季度财报  超过预期，主要原因是其注射美容部门的销售额增加。** 注射美容部门的销售额同比增长9.9%，Jefferies和J.P. Morgan的分析师指出，这比共识高出6%，主要是受到神经调节剂销售额的推动。** 美国销售额未达到一致预期，但国际销售额 \"令人愉悦的两位数 \"增长抵消了这一影响。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4T3R20KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836757.USD","LU1974910355.USD","LU1720051108.HKD","LU2552382132.HKD","LU1061106388.HKD","LU1069344957.HKD","BK4581","LU2471134523.USD","LU0823416689.USD","BK4599","LU0203201768.USD","LU1551013342.USD","LU1623119135.USD","LU2211815571.USD","LU2362541273.HKD","IE00BJJMRZ35.SGD","LU0079474960.USD","LU0354030511.USD","LU2361044949.HKD","LU0114720955.EUR","IE00BJT1NW94.SGD","REGN","LU1548497426.USD","SG9999014898.SGD","LU1712237335.SGD","SGXZ99366536.SGD","LU0672654240.SGD","LU0820561909.HKD","SG9999015986.USD","LU2471134952.CNY","LU1291159041.SGD","LU1814569148.SGD","SG9999013999.USD","LU2362540622.SGD","LU2461242641.AUD","SG9999018865.SGD","LU2063271972.USD","LU2360106947.USD","LU2468319806.SGD","LU0096364046.USD","SG9999015945.SGD","LU0320765992.SGD","LU2602419157.SGD","SGXZ57979304.SGD","SG9999018857.SGD","BK4139","SG9999017495.SGD","LU0053666078.USD","LU0882574055.USD"],"gpt_icon":1},{"id":"2529295436","title":"諾和諾德憑藉Wegovy大幅上調銷售指引的輝煌勢頭或近尾聲","url":"https://stock-news.laohu8.com/highlight/detail?id=2529295436","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529295436?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 14:59","pubTimestamp":1745477940,"startTime":"0","endTime":"0","summary":"自2021年推出广受欢迎的减肥药Wegovy以来，诺和诺德每年多次上调年度销售指引。诺和诺德2月曾表示，其已增加Wegovy在美国的供应以满足激增需求，并称指引已反映这一调整。诺和诺德及其竞争对手还面临产品被卷入美国总统特朗普发起的贸易战的风险。部分分析师预计，若美国食品药品监督管理局严格执行对仿制药的禁令，Wegovy和糖尿病药物Ozempic的处方量或会回升。诺和诺德称，该禁令可能将需求转向其正版产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424150139a464eda6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424150139a464eda6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","NVO","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4588"],"gpt_icon":1},{"id":"2529964793","title":"羅氏：美國的投資計劃不會犧牲世界其他地區的利益","url":"https://stock-news.laohu8.com/highlight/detail?id=2529964793","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529964793?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 14:25","pubTimestamp":1745475927,"startTime":"0","endTime":"0","summary":"路透4月24日 - 罗氏公司ROG.S.首席执行官周四表示，该公司本周早些时候宣布在美国进行大规模投资，但这并不会以牺牲全球其他地区的预算为代价。这家瑞士制药商周二表示， ，未来五年将在美国投资 500 亿美元，创造超过 12,000 个新的就业机会，这是公司为应对特朗普总统的关税政策而进行的最新大规模投资。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R20GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU1712237335.SGD","SG9999015952.SGD","LU0256863811.USD","LU0109391861.USD","LU0094547139.USD","LU2237438978.USD","LU0106261372.USD","SGXZ57979304.SGD","LU1127390331.HKD","IE00B2B36J28.USD","LU0820561909.HKD","SG9999014880.SGD","LU1267930730.SGD","LU0079474960.USD","IE00BJLML261.HKD","LU2552382215.SGD","SG9999014914.USD","SGXZ31699556.SGD","LU2237443382.USD","SG9999001176.SGD","LU2357305700.SGD","LU0096364046.USD","BK4599","LU0354030511.USD","LU2471134796.USD","LU2468319806.SGD","BK4533","LU0672654240.SGD","LU0708995401.HKD","LU0122379950.USD","LU1548497426.USD","LU0203202063.USD","LU1868837300.USD","LU2023250504.SGD","LU2089984988.USD","LU2237443895.HKD","SGXZ99366536.SGD","LU1057294990.SGD","LU2471134879.HKD","LU1093756325.SGD","LU1366192091.USD","LU1551013425.SGD","LU1917777945.USD","LU1035775433.USD","LU2237443549.SGD","SG9999017495.SGD","LU1814569148.SGD","LU2491050071.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":121,"code":"91000000","status":"200"}]}}